CN103750358A - 适宜三高人群食用的保健牛肉 - Google Patents
适宜三高人群食用的保健牛肉 Download PDFInfo
- Publication number
- CN103750358A CN103750358A CN201410038659.6A CN201410038659A CN103750358A CN 103750358 A CN103750358 A CN 103750358A CN 201410038659 A CN201410038659 A CN 201410038659A CN 103750358 A CN103750358 A CN 103750358A
- Authority
- CN
- China
- Prior art keywords
- parts
- beef
- hypertension
- hyperglycemia
- hyperlipidemia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000015278 beef Nutrition 0.000 title claims abstract description 24
- 230000036541 health Effects 0.000 title claims description 6
- 206010020772 Hypertension Diseases 0.000 title abstract description 9
- 201000001421 hyperglycemia Diseases 0.000 title abstract description 8
- 208000031226 Hyperlipidaemia Diseases 0.000 title abstract description 5
- 244000236655 Diospyros kaki Species 0.000 claims abstract description 19
- 235000011511 Diospyros Nutrition 0.000 claims abstract description 16
- 244000022372 Diospyros lotus Species 0.000 claims abstract description 10
- 235000003333 Diospyros lotus Nutrition 0.000 claims abstract description 10
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 10
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 10
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 10
- 244000268590 Euryale ferox Species 0.000 claims abstract description 8
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 7
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 7
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 7
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 7
- 244000291564 Allium cepa Species 0.000 claims abstract description 5
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 5
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 5
- 150000003839 salts Chemical class 0.000 claims abstract description 5
- 241000522254 Cassia Species 0.000 claims description 9
- 235000013399 edible fruits Nutrition 0.000 claims description 8
- 235000006487 Euryale ferox Nutrition 0.000 claims description 7
- 240000000249 Morus alba Species 0.000 claims description 6
- 235000008708 Morus alba Nutrition 0.000 claims description 6
- 235000013409 condiments Nutrition 0.000 claims description 5
- 235000002732 Allium cepa var. cepa Nutrition 0.000 claims description 4
- 239000008280 blood Substances 0.000 abstract description 18
- 210000004369 blood Anatomy 0.000 abstract description 18
- 230000000694 effects Effects 0.000 abstract description 15
- 239000003814 drug Substances 0.000 abstract description 5
- 235000013305 food Nutrition 0.000 abstract description 5
- 238000000034 method Methods 0.000 abstract description 5
- 230000036772 blood pressure Effects 0.000 abstract description 4
- 108090000623 proteins and genes Proteins 0.000 abstract description 4
- 102000004169 proteins and genes Human genes 0.000 abstract description 4
- 239000003963 antioxidant agent Substances 0.000 abstract description 3
- 230000003750 conditioning effect Effects 0.000 abstract description 3
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 abstract description 3
- JBYXPOFIGCOSSB-GOJKSUSPSA-N 9-cis,11-trans-octadecadienoic acid Chemical compound CCCCCC\C=C\C=C/CCCCCCCC(O)=O JBYXPOFIGCOSSB-GOJKSUSPSA-N 0.000 abstract description 2
- 229940108924 conjugated linoleic acid Drugs 0.000 abstract description 2
- 150000002632 lipids Chemical class 0.000 abstract description 2
- 235000013372 meat Nutrition 0.000 abstract description 2
- 239000013589 supplement Substances 0.000 abstract description 2
- 230000000451 tissue damage Effects 0.000 abstract description 2
- 231100000827 tissue damage Toxicity 0.000 abstract description 2
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 235000021511 Cinnamomum cassia Nutrition 0.000 abstract 1
- 239000004278 EU approved seasoning Substances 0.000 abstract 1
- 238000009835 boiling Methods 0.000 abstract 1
- 235000011194 food seasoning agent Nutrition 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 description 9
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- 235000008597 Diospyros kaki Nutrition 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 241001247821 Ziziphus Species 0.000 description 3
- 208000007502 anemia Diseases 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- 239000011800 void material Substances 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 108010028554 LDL Cholesterol Proteins 0.000 description 2
- 208000001132 Osteoporosis Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- HIMXGTXNXJYFGB-UHFFFAOYSA-N alloxan Chemical compound O=C1NC(=O)C(=O)C(=O)N1 HIMXGTXNXJYFGB-UHFFFAOYSA-N 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 230000003727 cerebral blood flow Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 230000001077 hypotensive effect Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 235000004213 low-fat Nutrition 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- NKDFYOWSKOHCCO-YPVLXUMRSA-N 20-hydroxyecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(C)(O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 NKDFYOWSKOHCCO-YPVLXUMRSA-N 0.000 description 1
- HXWZQRICWSADMH-SEHXZECUSA-N 20-hydroxyecdysone Natural products CC(C)(C)CC[C@@H](O)[C@@](C)(O)[C@H]1CC[C@@]2(O)C3=CC(=O)[C@@H]4C[C@@H](O)[C@@H](O)C[C@]4(C)[C@H]3CC[C@]12C HXWZQRICWSADMH-SEHXZECUSA-N 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 208000030090 Acute Disease Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- SXAMSIHRCZWLMU-UHFFFAOYSA-N Convallamarin Natural products CC1OC(OC2C(C)OC(OC3CC(CC4CCC5C(CCC6(C)C5CC7OC(O)(CCC(=C)COC8OC(CO)C(O)C(O)C8O)C(C)C67)C34C)OC9OC(CO)C(OC%10OC(C)C(O)C(O)C%10O)C(O)C9O)C(O)C2O)C(O)C(O)C1O SXAMSIHRCZWLMU-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- PQMOXTJVIYEOQL-UHFFFAOYSA-N Cumarin Natural products CC(C)=CCC1=C(O)C(C(=O)C(C)CC)=C(O)C2=C1OC(=O)C=C2CCC PQMOXTJVIYEOQL-UHFFFAOYSA-N 0.000 description 1
- 208000005156 Dehydration Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- DCEFCUHVANGEOE-UHFFFAOYSA-N Ecdysterone Natural products CC(CC(C)(C)O)C(O)C(C)(O)C1CCC2(O)C3=CC(=O)C4CC(O)C(O)CC4(C)C3CCC12C DCEFCUHVANGEOE-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 102000017011 Glycated Hemoglobin A Human genes 0.000 description 1
- 108010014663 Glycated Hemoglobin A Proteins 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 244000241872 Lycium chinense Species 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- FSOGIJPGPZWNGO-UHFFFAOYSA-N Meomammein Natural products CCC(C)C(=O)C1=C(O)C(CC=C(C)C)=C(O)C2=C1OC(=O)C=C2CCC FSOGIJPGPZWNGO-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010056720 Muscle mass Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 201000004239 Secondary hypertension Diseases 0.000 description 1
- 208000007180 Sunstroke Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- NKDFYOWSKOHCCO-UHFFFAOYSA-N beta-ecdysone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C)(O)C(O)CCC(C)(O)C)CCC33O)C)C3=CC(=O)C21 NKDFYOWSKOHCCO-UHFFFAOYSA-N 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 150000003943 catecholamines Chemical class 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- PSJVJZYSECBFHJ-BANYBNOTSA-N convallamarin Chemical compound O([C@@H]1[C@@H](C)O[C@H]([C@@H]([C@@H]1O)O)O[C@@H]1C[C@@H](C[C@H]2CC[C@H]3[C@@H]4C[C@H]5[C@@H]([C@]4(CC[C@@H]3[C@]21C)C)[C@@H]([C@@](O5)(O)CCC(=C)CO[C@H]1[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O1)O)C)O[C@H]1[C@@H]([C@H](O)[C@@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@@H](C)O1)O)[C@@H]1O[C@H](C)[C@H](O)[C@@H](O)[C@H]1O PSJVJZYSECBFHJ-BANYBNOTSA-N 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000020930 dietary requirements Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 230000002641 glycemic effect Effects 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 206010023332 keratitis Diseases 0.000 description 1
- 201000010666 keratoconjunctivitis Diseases 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000003680 myocardial damage Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L13/00—Meat products; Meat meal; Preparation or treatment thereof
- A23L13/40—Meat products; Meat meal; Preparation or treatment thereof containing additives
- A23L13/42—Additives other than enzymes or microorganisms in meat products or meat meals
- A23L13/428—Addition of flavours, spices, colours, amino acids or their salts, peptides, vitamins, yeast extract or autolysate, nucleic acid or derivatives, organic acidifying agents or their salts or acidogens, sweeteners, e.g. sugars or sugar alcohols; Addition of alcohol-containing products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L13/00—Meat products; Meat meal; Preparation or treatment thereof
- A23L13/10—Meat meal or powder; Granules, agglomerates or flakes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L13/00—Meat products; Meat meal; Preparation or treatment thereof
- A23L13/70—Tenderised or flavoured meat pieces; Macerating or marinating solutions specially adapted therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供一种适宜三高人群食用的牛肉，以实现三高协同调理。其用下述重量份原料按照如下方法制成：牛肉100-140，加入肉桂3-6、枸杞3-6、莲子3-6、山药3-6、玉竹3-6、芡实3-6、黑枣3-6、柿叶7-12、桑叶7-12，再加入葱、盐为调料，用水煮熟捞出即可。本发明多采用补中益气药食同源原料，均具有降压、降低血糖和血脂作用，同时牛肉不仅味道鲜美，而且醇厚，肉质口感非常的好，能补充人体所需的蛋白质，牛肉中脂肪含量很低，但却富含结合亚油酸，这些潜在的抗氧化剂可以有效对抗运动中造成的组织损伤。
Description
技术领域
本发明属于食品制造技术领域，特别是一种保健牛肉。
背景技术
“三高”是指：高血压，高血脂，高血糖。患有“三高”中任意一种疾病的患者称为三高人群。“三高”是心脑血管病的罪魁祸首，严重危害现代人健康。而且三高之间互相都有关系，特别是高血压与糖尿病都与高血脂关系密切，因此防治高血压病与糖尿病都应该同时降血脂。
三高人群饮食需要低糖、低脂，三高人群饮食因此受到很多限制。现有的调节三高的食品都功能单一，一般只适合某一种症状，无法实现三高协同调理。虽然牛肉相比较与大肉脂肪较低，但是传统制作方法对于三高人群控制低糖、低脂来说还是不够理想。
发明内容
本发明目的是提供一种适宜三高人群食用的牛肉，以实现三高协同调理。
适宜三高人群食用的保健牛肉，其用下述重量份原料按照如下方法制成：牛肉100-140，加入肉桂3-6、枸杞3-6、莲子3-6、山药3-6、玉竹3-6、芡实3-6、黑枣3-6、柿叶7-12、桑叶7-12，再加入葱、盐为调料，用水煮熟捞出即可。
本发明在制作牛肉过程中添加的肉桂对心血管系统有很好的保健作用：肉桂水提物及挥发油对大鼠在冰水应激状态下内源性儿茶酚胺分泌增加所致的血小板聚集及心肌损伤有一定对抗及保护作用；肉桂可使麻醉犬冠脉、脑血流量增加，血管阻力下降；肉桂水煎后期中的桂皮醛及香豆素对ADP诱导大鼠血小板聚集有抑制作用。肉桂还具有降压和控制血糖平衡，防止和治疗糖尿病。
枸杞子补肝肾，强筋骨，润肺，明目，主治胆肾阳虚，腰膝酸软，虚劳咳嗽，头目眩晕，目赤生翳，消渴等症。
莲子补脾止泻，益肾涩清，养心安神，用于脾虚久泻，遗精带下，心悸失眠，主治夜寐多梦，失眠，健忘，心烦口渴，腰痛脚弱，耳目不聪，遗精，淋浊，久痢，虚泻。而且证明莲子具有防癌抗癌营养保健功能。莲子所含非结晶形生物碱N－9有降血压作用。
山药健脾益胃助消化，滋肾益精，强健机体，滋肾益精的作用。大凡肾亏遗精、妇女白带多、小便频数等症，皆可服之。有降低血糖的作用。可用于治疗糖尿病，是糖尿病人的食疗佳品。
玉竹对阴虚外感，头昏眩晕，筋脉挛痛具有疗效。玉竹对心脏的作用与其中所含的铃兰苦甙、铃兰甙有关，适合治疗心悸、心绞痛;对血压的作用：静脉注射可使血压暂时下降;对血糖的影响：口服玉竹浸膏，则血糖先升后降，对肾上腺素引起的高血糖有显著的抑制作用，对葡萄糖、四氧嘧啶引起的大鼠高血糖也有抑制作用，可用于糖尿病;玉竹中有抗氧化作用的成分，可调节人体免疫力，抑制肿瘤的生长。
芡实补中益气，为滋养强壮性食物，和莲子有些相似，但芡实的收敛固精作用比莲子强，适用于慢性泄泻和小便频数，梦遗滑精，妇女带多腰酸等。芡实是健脾补肾的绝佳首选，若能与山药同舟共济，那补益的效果就更佳了。
黑枣能补中益气，养胃健脾，养血壮神，润心肺，调营卫、生津液，悦颜色，通九窍，助十二经，解药毒，调和百药。黑枣的作用一：
能提高人体免疫力，并可抑制癌细胞：药理研究发现，红枣能促进白细胞的生成，降低血清胆固醇，提高血清白蛋白，保护肝脏，红枣中还含有抑制癌细胞，甚至可使癌细胞向正常细胞转化的物质。黑枣的作用二：经常食用鲜枣的人很少患胆结石，这是因为鲜枣中丰富的维生素C，使体内多余的胆固醇转变为胆汁酸。胆固醇少了，结石形成的概率也就随之减少。黑枣的作用三：枣中富含钙和铁，它们对防治骨质疏松产贫血有重要作用：中老年人更年期经常会骨质疏松，正在生长发育高峰的青少年和女性容易发生贫血，大枣对他们会有十分理想的食疗作用，其效果通常是药物不能比拟的;黑枣的作用对病后体虚的人也有良好的滋补作用。
柿子叶中含有大量丹宁酸，如果使用柿子叶来泡澡可是有好处的，这些物质通过渗透到水中可以有效的杀灭各种细菌和真菌，具有清洁和滋润皮肤的功效，是最简单又有季节感的美容方法。柿树叶除含有相当可观的蛋白质、氨基酸及多种维生素外，还有胆碱、芦丁和丹宁，具有抗菌、消炎、活血、降压、降脂、抗癌作用，特别是它含的维生素C可达1800mg/100g，远高于常见的水果和蔬菜。它能抗坏血病，防治支气管炎、防癌、抗癌。柿叶茶防治动脉硬化、高血压、冠心病的功能食品和药物。
桑叶具有降血压、血脂、抗炎等作用。实验证明，桑叶所含的蜕皮甾酮对多种方法诱导的血糖升高均有降糖作用，可促进葡萄糖转化为糖元，但不改变正常动物的血糖。
本发明多采用补中益气药食同源原料，均具有降压、降低血糖和血脂作用，同时牛肉不仅味道鲜美，而且醇厚，肉质口感非常的好，能补充人体所需的蛋白质，牛肉中脂肪含量很低，但却富含结合亚油酸，这些潜在的抗氧化剂可以有效对抗运动中造成的组织损伤。另外，亚油酸还可以作为抗氧化剂保持肌肉块。通过这些烹饪原料的添加，不仅适宜于生长发育、术后、病后调养的人、中气下隐、气短体虚、筋骨酸软、贫血久病及面黄目眩之人食用;也适合感染性疾病、肝病、肾病的人慎食;黄牛肉为发物，患疮疥湿疹、痘痧、瘙痒者慎用。特别是适合高胆固醇、高脂肪和高血糖、高血压人群食用。
具体实施方式
牛肉100-140，加入肉桂3-6、枸杞3-6、莲子3-6、山药3-6、玉竹3-6、芡实3-6、黑枣3-6、柿叶7-12、桑叶7-12，再加入葱、盐为调料，用水煮熟捞出即可。
本发明由于采用原料均为药食同源调料烹制牛肉，没有毒副作用，在2012年1月自2013年11月期间经过258名有三高症状的人群连续每天以实施例制作的牛肉6个月，食用者均为患有三高病症多年，平均年龄超过49.2岁，并且多人同时交叉患有三高症。在期间不改变原有饮食、用药习惯，每日食用本发明制作牛肉200-300克。6个月后统计结果如下：
统计其中124名有继发性高血压症状者中，服用前血压160—179/100—109mmHg，均有下降，同时伴有脑出血、心力衰竭、肾功能衰竭等病变得到一定程度控制。
其中108人有继发性高脂血症服用前LDL-C浓度>130mg/dl，食用6个月后LDL-C浓度<100mg/dl。
其中97人自述患有糖尿病，并在开始前测血糖：2h血糖≥12.2mmol/L；IGT：2h血糖≥8.9mmol/L且<12.2mmol/L，诊断为糖尿病。食用6个月后，测量糖化血红蛋白，HbA1c3.8-6.9%，说明在食用后血糖控制比较理想。
Claims (2)
1.适宜三高人群食用的保健牛肉，其特征是用下述重量份原料按照如下方法制成：牛肉100-140，加入肉桂3-6、枸杞3-6、莲子3-6、山药3-6、玉竹3-6、芡实3-6、黑枣3-6、柿叶7-12、桑叶7-12，再加入葱、盐为调料，用水煮熟捞出即可。
2.根据权利要求1所述的适宜三高人群食用的保健牛肉，其特征是用下述重量份原料按照如下方法制成：牛肉120、肉桂5、枸杞5、莲子5、山药5、玉竹5、芡实5、黑枣5、柿叶10、桑叶10，再加入葱、盐为调料，用水煮熟捞出即可。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410038659.6A CN103750358B (zh) | 2014-01-27 | 2014-01-27 | 适宜三高人群食用的保健牛肉 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410038659.6A CN103750358B (zh) | 2014-01-27 | 2014-01-27 | 适宜三高人群食用的保健牛肉 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103750358A true CN103750358A (zh) | 2014-04-30 |
| CN103750358B CN103750358B (zh) | 2015-12-09 |
Family
ID=50517811
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410038659.6A Expired - Fee Related CN103750358B (zh) | 2014-01-27 | 2014-01-27 | 适宜三高人群食用的保健牛肉 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103750358B (zh) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104432125A (zh) * | 2014-11-07 | 2015-03-25 | 安徽老炊食品有限公司 | 一种增强肉质强度的降压降脂牛肉 |
| CN104522684A (zh) * | 2014-11-12 | 2015-04-22 | 安徽省固镇县争华羊业有限公司 | 白术健脾益气型牛肉及其制备方法 |
| CN106578981A (zh) * | 2016-12-20 | 2017-04-26 | 重庆市长寿区舒福食品有限公司 | 一种速冻降糖牛肉 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1103262A (zh) * | 1993-11-27 | 1995-06-07 | 赵忠祥 | 一种保健食品及其制作方法 |
| CN1153614A (zh) * | 1995-12-07 | 1997-07-09 | 李缯宏 | 野味泥鳅鱼 |
| CN101138423A (zh) * | 2007-08-09 | 2008-03-12 | 于洪文 | 药膳牛肉 |
-
2014
- 2014-01-27 CN CN201410038659.6A patent/CN103750358B/zh not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1103262A (zh) * | 1993-11-27 | 1995-06-07 | 赵忠祥 | 一种保健食品及其制作方法 |
| CN1153614A (zh) * | 1995-12-07 | 1997-07-09 | 李缯宏 | 野味泥鳅鱼 |
| CN101138423A (zh) * | 2007-08-09 | 2008-03-12 | 于洪文 | 药膳牛肉 |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104432125A (zh) * | 2014-11-07 | 2015-03-25 | 安徽老炊食品有限公司 | 一种增强肉质强度的降压降脂牛肉 |
| CN104522684A (zh) * | 2014-11-12 | 2015-04-22 | 安徽省固镇县争华羊业有限公司 | 白术健脾益气型牛肉及其制备方法 |
| CN106578981A (zh) * | 2016-12-20 | 2017-04-26 | 重庆市长寿区舒福食品有限公司 | 一种速冻降糖牛肉 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103750358B (zh) | 2015-12-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101090284B1 (ko) | 홍삼과 녹용 추출물을 포함하는 드링크제 및 그의 제조방법 | |
| CN103416760B (zh) | 治疗和预防肌肉衰减综合症的五谷杂粮全营养配方食品 | |
| CN103416625B (zh) | 一种大麦型仔猪饲料及其制备方法 | |
| CN101023802A (zh) | 全营养绿色保健粉（丝、条）和方便（速食）粉（丝、条）系列产品及其制作方法 | |
| CN102526479B (zh) | 一种增强免疫力、降血糖功能的保健药物 | |
| CN104286273A (zh) | 铁皮石斛的用途及其茶叶制品 | |
| CN105454576A (zh) | 茉莉花八宝茶及其制备方法 | |
| CN106562413A (zh) | 一种提高免疫力膏滋及其制备方法 | |
| CN103750358B (zh) | 适宜三高人群食用的保健牛肉 | |
| CN105685317A (zh) | 富含硒火麻茶及其制备方法 | |
| CN108887683A (zh) | 一种药食养生的米饭添加剂及其制备工艺和药食养生米饭 | |
| CN106723048B (zh) | 一种用于缓解疲劳的保健食品及其制备方法 | |
| CN103463625B (zh) | 养心补血营养制剂 | |
| CN103263054B (zh) | 一种降血压功能性饮品 | |
| CN102835708A (zh) | 一种含有多种矿物质的保健饮料 | |
| CN107950862A (zh) | 一种红枣羹及其制作方法 | |
| CN103330175A (zh) | 一种天然植物组合物调味品及其制备方法 | |
| CN109527577A (zh) | 一种具有解酒护肝功能的组合物 | |
| CN103815080B (zh) | 苦荞速溶茶及其制备方法 | |
| KR20090038595A (ko) | 보양식 순대소 조성물 및 그를 이용한 순대 제조방법 | |
| CN1994129A (zh) | 一种海参营养素及其生产方法 | |
| CN107125751A (zh) | 龟粉、制备方法及其应用 | |
| CN105995702A (zh) | 一种保健调味薇菜 | |
| CN110122750A (zh) | 一种健康营养八宝粥 | |
| CN110050911A (zh) | 五谷养生露 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20151209 Termination date: 20170127 |